In this week’s View, Dr. Eagle looks at a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF that explores sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction. He then covers the potential impact of pulmonary valve replacement in repaired tetralogy of Fallot. Finally, Dr. Eagle discusses a very large study on transcatheter mitral valve repair for degenerative mitral regurgitation. 

Subscribe to Eagle’s Eye View